AI Maverick Intel Inc. (OTCID: AIMV) has entered into a definitive share purchase agreement to acquire Heal Access Canada Inc., an artificial intelligence healthcare technology company, from its controlling stockholder, HEAL Group Holdings Inc. The announcement, reported by TechMediaWire, marks a significant step for AIMV as it seeks to expand its presence in the AI-driven healthcare sector.
The transaction includes $5 million in consideration through a secured, two-year promissory note bearing 10% annual interest, plus 20 million exchangeable shares convertible into AIMV common stock. Heal Access operates an AI-powered healthcare intelligence platform that integrates patient information and supports clinical workflows. The platform is operational in five countries and serves more than 118,000 patients, demonstrating its commercial viability and potential for scalability.
The acquisition remains subject to several closing conditions, including at least $6 million in financing and independent special committee ratification. AIMV expects to use commercially reasonable efforts to complete the required financing by Dec. 31, 2026, with either party permitted to terminate the agreement if the transaction has not closed by Feb. 28, 2027. Additionally, AIMV will assume approximately $6.4 million in existing obligations owed by Heal Access and its subsidiaries to HEAL Group and affiliates.
AIMV clarified that its Sept. 21 announcement incorrectly described the acquisition agreement as definitive, noting that the binding agreement was signed Oct. 12, 2026. Upon conversion of all exchangeable shares, HEAL Group would hold approximately 80.1% of AIMV common stock before accounting for any shares issued in the financing. This significant ownership stake underscores HEAL Group’s continued commitment to the combined entity’s success.
The acquisition is important because it positions AIMV to capitalize on the growing demand for AI in healthcare, a sector increasingly reliant on data integration and intelligent workflow solutions. By acquiring Heal Access, AIMV gains an operational platform with a proven track record across multiple countries, potentially accelerating its revenue growth and market penetration. Furthermore, the deal aligns with AIMV’s strategy to grow through further acquisitions of AI and technology-enabled healthcare businesses, including opportunities under its right of first refusal agreement with HEAL Group Holdings Inc.
For investors, the transaction highlights the risks and rewards of emerging AI healthcare ventures. The financing condition and the substantial ownership concentration post-conversion are key factors to monitor. The latest news and updates relating to AIMV are available in the company’s newsroom at http://ibn.fm/AIMV.
TechMediaWire, a specialized communications platform focused on pioneering technology companies, is part of the Dynamic Brand Portfolio within IBN, which provides access to wire solutions via InvestorWire and editorial syndication to 5,000+ outlets, among other services. For full terms of use and disclaimers, see https://www.TechMediaWire.com/Disclaimer.
